Works matching AU Stager, William


Results: 9
    1
    2
    3

    Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide ( iGlarLixi) vs insulin glargine and lixisenatide monocomponents

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1798, doi. 10.1111/dom.12980
    By:
    • Davies, Melanie J.;
    • Leiter, Lawrence A.;
    • Guerci, Bruno;
    • Grunberger, George;
    • Ampudia‐Blasco, F. Javier;
    • Yu, Christine;
    • Stager, William;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Rosenstock, Julio
    Publication type:
    Article
    4
    5

    Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) vs insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 10, p. 1408, doi. 10.1111/dom.12961
    By:
    • Wysham, Carol;
    • Bonadonna, Riccardo C.;
    • Aroda, Vanita R.;
    • Puig Domingo, Manuel;
    • Kapitza, Christoph;
    • Stager, William;
    • Yu, Christine;
    • Niemoeller, Elisabeth;
    • Souhami, Elisabeth;
    • Bergenstal, Richard M.
    Publication type:
    Article
    6
    7
    8
    9